Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Analysis
Comment
Deals
Events
News
People

Series C

Corporates help ship $200m to Xingyun
Xingyun has picked up $200m in a series C round co-led by Taikang Insurance, Shanghai United Media Group and Highlight Capital, while GLP and C&D Group also invested.
RoadRunner blazes into series C extension
Avery Dennison and Valo Ventures both invested to lift recycling service provider RoadRunner's series C total to $38.9m.
XWPharma takes in $40m series C round
Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.
Beyond Limits lines up $133m series C
Group 42 has joined existing shareholder BP Ventures to co-lead a series C round for Caltech and Nasa spinout Beyond Limits, with $113m already closed and another $20m committed.
Virogin Biotech transmits $62m series C
Backed by Sinopharm Capital previously, Virogin Biotech will invest the series C proceeds in its clinical drug programmes and securing industry partnerships.
Corporates meet Novellus in $57m series C
Precision cancer drug developer Novellus boosted its funding total to $75.5m with a round featuring SR One and Novartis Venture Fund.
Leyan locks in series C2
The Kunlun-backed customer engagement software provider has closed its series C round at about $44m, having raised a similar amount in series C1 funding four months ago.

Other News

Corporates floor Lava with $83m
Novo Ventures and Sanofi Ventures co-led a series C round for the cancer therapy developer with backing from returning investor MRL Ventures Fund.
Ready gets $54m response to 2020 growth
GV participated in a round that increased the on-demand healthcare service's overall funding to $107m, with the cash to go to expanding its operations.
Infarm produces $170m for series C
Bonnier contributed to the $170m first close of a the urban farming technology developer's series C round, taking its debt and equity financing to at least $305m.
Leleketang lets in $40m
New Oriental Education and Culture Industrial Fund contributed to a series C round that lifted the educational content provider's total funding to $85m.
Groww thrives with $30m series C
BBVA-backed Propel Venture Partners has returned for a round that will help Groww add more asset classes to its online investment service.

Editor's Picks

Joby ascends with $590m
The aerial electric taxi developer increased its overall funding to $720m in a series C round led by a $394m investment from Toyota.
Sub-$50m Investment of the Year: Maana
Maana recently won GCV’s inaugural award for energy-tech corporate venture capital (CVC) investment of the year, presented during its Venture Houston conference in November. Now, Maana has gone one-stage further and won the Sub-$50m Investment of the Year award across all industries.
Relay Therapeutics runs away with $400m
SoftBank Vision Fund led a series C round for the cancer therapy developer that was also backed by GV and Alexandria Venture Investments.
Zymergen climbs to $400m series C
The molecular product technology provider followed a nine-figure, SoftBank-led round two years ago with a series C led by the corporate's Vision Fund.
test reg

Login